USPTO 2015–2025 USPTO PatentsView US Corporation

ICP Construction, Inc.

USPTO PatentsView assignee record - 13 granted patents across 19 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B05B (Spraying APPARATUS; Atomising APPARATUS; Nozzles).

RSS updates for this company

The verdict

According to USPTO PatentsView, ICP ranks #21,251 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 19 technology areas.

#21,251
of 49,997 US assignees by volume
Top 11%
by Innovation Score (51.4/100)
11.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R21251 · US Corporation #21,251 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 13 grants
  • MID-PACK #21,251/49,997
  • PHOTO-FINISH I-mab Biopharma US
  • CPC-FOCUS B05B · 19 areas
  • INNOV-PAR 51.4/100
  • CLAIMS-PAR 11.4 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: I-mab Biopharma US Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How ICP’s 51.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around ICP

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows ICP's Innovation Score is 51.4/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for ICP?

Each dot is one of ICP’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). ICP’s own 11.4 claims/patent is ABOVE the 10.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

ICP vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 12.912.91313.1 0510152025 Granted patents (volume) Avg claims / patent I-mab Biopharma US Limited - 13, 14.31I-mab Biopharma USI.G. Bauerhin GMBH - 13, 14.62I G BauerhinI/O Interconnect, Ltd. - 13, 10.77I/O InterconnectICE Benchmark Administration Limited - 13, 21.23ICE Benchmark Adm…ID Development Limited - 13, 4.15ID DevelopmentIdeaforge Technology PVT. Ltd. - 13, 9.85Ideaforge Technol…IEI Integration Corp. - 13, 8.77IEI IntegrationIflytek Co., Ltd. - 13, 16.54IflytekICP Construction, Inc. - 13, 11.38ICP Construction
ICP vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where ICP's grants concentrate

ICP Construction, Inc. is a focused PatentsView assignee: 19 CPC subclasses with 46.2% of grants classified under B05B (Spraying APPARATUS; Atomising APPARATUS; Nozzles). Peak complete grant year is 2023 (7 grants) versus a trough of 2 in 2021. By volume, ICP sits between I-mab Biopharma US Limited and Iflytek Co., Ltd..

ICP's three-year grant acceleration

ICP Construction, Inc. shows 9 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at ICP's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows ICP holds 13 patents at rank #21,249, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near ICP

By rank, the assignees closest to #21,249 in granted patent volume.

Leaders in B05B (Spraying Apparatus)

Other assignees with the most granted patents in ICP's primary technology class.

ICP's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 11% higher than 89% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2021202220232025 2
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
ICP Construction, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 2 15.4%
2022 2 15.4%
2023 7 53.8%
2025partial year 2 15.4%

Which technologies does ICP Construction, Inc. patent most?

Top 15 of 19 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

ICP Construction, Inc.'s patent record in context - here's where to go next.

  • ICP Construction, Inc.'s lead technology class is B05B (Spraying APPARATUS; Atomising APPARATUS; Nozzles), 46.2% of its portfolio - see every assignee active in that class. Explore B05B
  • Ranked #21,251 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare ICP Construction, Inc. against I-mab Biopharma US Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 51.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.